" I just wanted to tell you that loperamide WILL WORK" : A web-based study of extra-medical use of loperamide

Drug and Alcohol Dependence

Volumn 130, Issue 1-3, 2013, Pages 241-244

  Daniulaityte, Raminta ^a   Carlson, Robert ^a   Falck, Russel ^a   Cameron, Delroy ^b   Perera, Sujan ^b   Chen, Lu ^b   Sheth, Amit ^b  

^a WRIGHT STATE UNIVERSITY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Illicit opiod use; Loperamide; Self treatment; Web based research

Indexed keywords

ILLICIT DRUG; LOPERAMIDE;

ARTICLE; DATA BASE; DRUG INDICATION; DRUG USE; HUMAN; INTERNET; OPIATE ADDICTION; PRIORITY JOURNAL; WEBSITE; WITHDRAWAL SYNDROME;

ADVERTISING AS TOPIC; ANALGESICS, OPIOID; HUMANS; INTERNET; LOPERAMIDE; OPIOID-RELATED DISORDERS; SELF CARE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 84877014785     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.11.003     Document Type: Article

References (42)

1. Ahmad S.R. Lomotil overdose. Pediatrics 1992, 89:980-981.
2. Bhutta T.I., Balchin C. Assessing the impact of a regulatory intervention in Pakistan. Soc. Sci. Med. 1996, 42:1195-1202.
3. Bhutta T.I., Tahir K.I. Loperamide poisoning in children. Lancet 1990, 335:363.
4. Bogenschutz M.P. Drug information libraries on the Internet. J. Psychoactive Drugs 2000, 32:249-258.
5. Boyer C. Realizing the potential of the internet for health and medical information. Stud. Health Technol. Inform. 2004, 100:159-163.
6. Boyer E.W., Babu K.M., Macalino G.E. Self-treatment of opioid withdrawal with a dietary supplement, Kratom. Am. J. Addict. 2007, 16:352-356.
7. Boyer E.W., Lapen P.T., Macalino G., Hibberd P.L. Dissemination of psychoactive substance information by innovative drug users. Cyberpsychol. Behav. 2007, 10:1-6.
8. Boyer E.W., Shannon M., Hibberd P.L. The Internet and psychoactive substance use among innovative drug users. Pediatrics 2005, 115:302-305.
9. Boyer E.W., Shannon M., Hibberd P.L. Web sites with misinformation about illicit drugs. N. Engl. J. Med. 2001, 345:469-471.
10. Butler S.F., Budman S.H., Licari A., Cassidy T.A., Lioy K., Dickinson J., Brownstein J.S., Benneyan J.C., Green T.C., Katz N. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse. Pharmacoepidemiol. Drug Saf. 2008, 17:1142-1154.
11. Butler S.F., Venuti S.W., Benoit C., Beaulaurier R.L., Houle B., Katz N. Internet surveillance: content analysis and monitoring of product-specific internet prescription opioid abuse-related postings. Clin. J. Pain 2007, 23:619-628.
12. Carlson R.G., Wang J., Siegal H.A., Falck R.S., Guo J. An ethnographic approach to targeted sampling: problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Hum. Organization 1994, 53:279-286.
13. Cicero T.J., Adams E.H., Geller A., Inciardi J.A., Munoz A., Schnoll S.H., Senay E.C., Woody G.E. A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States. Drug Alcohol Depend. 1999, 57:7-22.
14. Cicero T.J., Ellis M.S., Surratt H.L. Effect of abuse-deterrent formulation of OxyContin. N. Engl. J. Med. 2012, 367:187-189.
15. Cone E.J. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet. Drug Alcohol Depend. 2006, 83(Suppl. 1):S31-S39.
16. Coplan P., Kale H., Sandstrom L., Chilcoat H.D. National changes in OxyContin, other oxycodone, and heroin exposures reported to poison centers with introduction of reformulated OxyContin. Presented at 74th Annual Meeting of College on Problems of Drug Dependence - June, 9-14, 2012 2012.
17. Daniulaityte R., Falck R., Carlson R.G. Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids. Drug Alcohol Depend. 2012, 122:201-207.
18. Deluca P., Schifano F., Psychonaut Research Group Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA). Am. J. Addict. 2007, 16:479-483.
19. DeVeaugh-Geiss A., Leukefeld C., Havens J., Coplan H., Chilcoat H. Routes of administration and frequency of abuse of OxyContin and immediate-release Oxycodone in a rural Kentucky County following introduction of reformulated OxyContin. Presented at the 74th Annual Meeting of College on Problems of Drug Dependence - June, 9-14, 2012 2012.
20. Ericsson C.D., Johnson P.C. Safety and efficacy of loperamide. Am. J. Med. 1990, 88:10S-14S.
21. Falck R.S., Carlson R.G., Wang J., Siegal H.A. Sources of information about MDMA (3,4-methylenedioxymethamphetamine): perceived accuracy, importance, and implications for prevention among young adult users. Drug Alcohol Depend. 2004, 74:45-54.
22. Fletcher P., Steffen R., DuPont H. Benefit/risk considerations with respect to OTC-de-scheduling of loperamide. Arzneimittelforschung 1995, 45:608-613.
23. Friedli G., Haenggeli C.A. Loperamide overdose managed by naloxone. Lancet 1980, 1:1413.
24. Griffiths P., Vingoe L., Hunt N., Mounteney J., Hartnoll R. Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption?. Subst. Use Misuse 2000, 35:811-844.
25. Gussin R.Z. Withdrawal of loperamide drops. Lancet 1990, 335:1603-1604.
26. Halpern J.H., Pope H.G. Hallucinogens on the Internet: a vast new source of underground drug information. Am. J. Psychiatry 2001, 158:481-483.
27. Lange J.E., Daniel J., Homer K., Reed M.B., Clapp J.D. Salvia divinorum: effects and use among YouTube users. Drug Alcohol Depend. 2010, 108:138-140.
28. Litovitz T., Clancy C., Korberly B., Temple A.R., Mann K.V. Surveillance of loperamide ingestions: an analysis of 216 poison center reports. J. Toxicol. Clin. Toxicol. 1997, 35:11-19.
29. Marcovitch H. Loperamide in toddler diarrhea. Lancet 1980, 1:1413.
30. McCabe S.E., Cranford J.A., West B.T. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addict. Behav. 2008, 33:1297-1305.
31. Miller P.G., Sonderlund A.L. Using the internet to research hidden populations of illicit drug users: a review. Addiction 2010, 105:1557-1567.
32. Minton N.A., Henry J.A. Loperamide poisoning in children. Lancet 1990, 335:788.
33. Minton N.A., Smith P.G. Loperamide toxicity in a child after a single dose. Br. Med. J. (Clin. Res. Ed.) 1987, 294:1383.
34. Monte A.A., Mandell T., Wilford B.B., Tennyson J., Boyer E.W. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J. Addict. Dis. 2009, 28:226-231.
35. Mounteney J., Fry C., McKeganey N., Haugland S. Challenges of reliability and validity in the identification and monitoring of emerging drug trends. Subst. Use Misuse 2010, 45:266-287.
36. Real Drugs in a Virtual World 2007, Lexington Books, Lanham, MD. E. Murguia, M. Tackett-Gibson, A. Lessem (Eds.).
37. Neuendorf K.A. Reliability for content analysis. Media Messages and Public Health: a Decisions Approach to Content Analysis 2009, 67-87. Routledge, New York. A.B. Jordan, D. Kunkel, J. Manganello, M. Fishbein (Eds.).
38. Nielsen S., Barratt M.J. Prescription drug misuse: is technology friend or foe?. Drug Alcohol Rev. 2009, 28:81-86.
39. Schifano F., Deluca P., Baldacchino A., Peltoniemi T., Scherbaum N., Torrens M., Farre M., Flores I., Rossi M., Eastwood D., Guionnet C., Rawaf S., Agosti L., Di Furia L., Brigada R., Majava A., Siemann H., Leoni M., Tomasin A., Rovetto F., Ghodse A.H. Drugs on the web; the Psychonaut 2002 EU project. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:640-646.
40. Sloboda Z. Epidemiology of Drug Abuse 2005, Springer, New York, NY.
41. Sudweeks F., Simoff S.J. Complementary explorative data analysis: the reconciliation of qualitative and quantitative principles. Doing Internet Research: Critical Issues and Methods for Examining the Net 1999, 29-56. Sage Publications, Thousand Oaks, CA. S. Jones (Ed.).
42. Wax P.M. Just a click away: recreational drug Web sites on the Internet. Pediatrics 2002, 109:e96.